Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kintara Therapeutics, Inc (KTRA)  
$0.08 0.00 (0.00%) as of 4:30 Fri 11/11


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 1,680,000
Market Cap: 141.29(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.0841 - $0.0841
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kintara Therapeutics is a clinical stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. Co.'s two primary candidates are: VAL-083, a validated, DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late-stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-14 2023-12-12 2023-06-13 2022-06-13

   
Records found: 191
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brown Dennis M Chief Scientific Officer   •       •       •   2015-07-22 4 B $0.60 $45,000 I/I 75,000 3,027,542 2.64     -
   Bell John K Director   –       •      –    2015-07-16 4 B $0.60 $30,000 I/I 50,000 137,000 2.1     -
   Garner William J Director   –       •      –    2015-07-16 4 B $0.60 $10,000 D/D 16,666 2,415,207 2.39     -
   Bacha Jeffrey President, CEO   •       •       •   2015-07-16 4 B $0.60 $30,000 D/D 50,000 113,485 3.23     -
   Praill Scott Chief Financial Officer   •       –      –    2015-07-16 4 B $0.60 $30,000 D/D 50,000 60,000 2.74     -
   Bacha Jeffrey CEO and President   •       •      –    2015-01-22 4 B $0.65 $4,925 D/D 7,500 63,485 2.73     -
   Bacha Jeffrey CEO and President   •       •       •   2014-12-09 4 B $0.90 $2,250 D/D 2,500 55,985 3.15     -
   Bacha Jeffrey CEO and President   •       •       •   2014-11-26 4 B $0.92 $2,300 D/D 2,500 53,485 3.15     -
   Bell John K Director   –       •      –    2014-11-21 4 B $0.95 $7,600 I/I 8,000 87,000 2.1     -
   Garner William J Director   –       •      –    2014-10-28 4 A $0.00 $0 D/D 2,388,541 2,398,541     -
   Brown Dennis M Chief Scientific Officer   •       •       •   2014-09-30 4 A $1.00 $278,530 I/I 278,530 278,530     -
   Bacha Jeffrey CEO and President   •       •      –    2014-09-18 4 B $0.98 $3,920 D/D 4,000 50,985 2.73     -
   Bacha Jeffrey CEO and President   •       •       •   2014-09-15 4 B $0.75 $3,739 D/D 4,985 46,985 3.15     -
   Bell John K Director   –       •      –    2014-09-08 4 B $0.71 $4,970 D/D 7,000 79,000 2.31     -
   Bell John K Director   –       •      –    2014-09-04 4 B $0.78 $6,237 D/D 8,000 72,000 2.39     -
   Bell John K Director   –       •      –    2014-04-22 4 B $1.25 $25,000 D/D 20,000 64,000 2.39     -
   Bell John K Director   –       •      –    2014-03-18 4 B $1.30 $32,500 D/D 25,000 44,000 2.39     -
   Garner William J Director   –       •      –    2014-03-18 4 S $1.30 $104,000 D/D (80,000) 10,000     -
   Garner William J Director   –       •      –    2014-03-18 4 A $0.00 $0 D/D 80,000 90,000     -
   Bacha Jeffrey CEO and President   •       •       •   2014-03-18 4 B $1.30 $13,000 D/D 10,000 42,000 3.15     -
   Praill Scott CFO   •       –      –    2014-03-18 4 B $1.30 $13,000 D/D 10,000 10,000 2.74     -
   Toth Robert Joseph Jr Director   –       •      –    2014-03-18 4 B $1.30 $32,500 D/D 25,000 43,500 2.39     -
   Brown Dennis M Chief Scientific Officer   •       •       •   2014-03-18 4 B $1.30 $13,000 D/D 10,000 2,952,542 3.15     -
   Brown Dennis M Chief Scientific Officer   •       •       •   2014-03-04 4 B $1.56 $7,808 D/D 5,000 2,942,542 3.15     -
   Bacha Jeffrey CEO and PRESIDENT   •       •       •   2014-02-21 4 B $1.00 $5,000 D/D 5,000 32,000 3.15     -
  191 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us